The Effectiveness of a Mobile Game Intervention in Alcohol Use Disorder

NCT ID: NCT07103785

Last Updated: 2025-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-11

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to evaluate the effectiveness of a mobile game application targeting attentional bias modification for alcohol stimuli in patients with Alcohol Use Disorder. Attentional bias is the tendency for individuals to pay more attention to some environmental stimuli than others. Previous evidence suggests that attentional bias for alcohol stimuli is associated with severity of drinking and craving. The research questions are as follows;

* Does the developed mobile game application reduce the attentional bias related to alcohol?
* Does the developed mobile game application reduce alcohol craving severity?
* Does the developed mobile game application reduce the severity of alcohol drinking? The researchers will evaluate the effectiveness of the mobile game, which aims to reduce attentional bias to alcohol stimuli, as standard treatment for Alcohol Use Disorder (medical treatment) versus standard treatment + mobile game application group.

Participants,

* Comply with the medical treatment prescribed by the doctor
* Use the mobile gaming app every other day for one month
* Come back in a month for an evaluation
* Be available for a telephone interview three months after the first interview

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Alcohol Use Disorder (AUD) is a significant public health problem that has far-reaching consequences for the well-being of individuals, families, and society. Recent studies have demonstrated that attentional bias for alcohol-related stimuli is associated with several variables, including alcohol craving, alcohol consumption behavior, and relapse following treatment. Therefore, interventions aimed at modifying attentional bias for alcohol cues have been a subject of scholarly interest.

The literature shows that, in addition to psychotherapeutic strategies, computerized versions of conventional attentional bias assessment instruments-referred to as Attentional Bias Modification (ABM)-have been utilized to decrease alcohol-related attentional bias. Some research indicates that ABM training produces results similar to psychotherapeutic treatments. ABM has the benefits of fewer interaction demands, time, and geographical limitations.

Gamified ABM methods have displayed encouraging impacts in decreasing craving, substance use, and relapse in different types of addiction. Nevertheless, research assessing gamified ABM treatments in people specifically diagnosed with AUD is still limited. Due to this shortage, an investigation of the effectiveness of gamified ABM treatments for AUD is deemed both timely and essential. Notably, most current ABM games for AUD have been created for desktop and laptop computers. Considering the extensive availability of mobile devices, providing such treatments through mobile devices will likely boost reach and user acceptance.

To meet these requirements, the current study created a gamified mobile ABM treatment to decrease attentional bias for alcohol cues in patients diagnosed with AUD. In the first phase, qualitative content analysis was gathered, and expert and patient feedback on the game was analyzed. The game was adjusted, and its final version was prepared according to this feedback.

The game's efficacy was tested in a tertiary care hospital in a northwestern province of Türkiye. Sixty subjects were enrolled-30 in the intervention group and 30 in the control group. All the subjects were given standard medical therapy as prescribed by a physician. Besides, the intervention group was also asked to use the mobile game developed for altering alcohol-related attentional bias. They were told to play the game every other day for a month.

The participants filled out the Penn Alcohol Craving Scale (PACS), the Alcohol Use Disorders Identification Test (AUDIT), and the Dot-Probe Task as pre- and post-tests. Three months following the post-test, follow-up data were gathered through phone interviews. Statistical analysis through chi-square tests, independent samples t-tests, and linear mixed models will be used to assess intervention efficacy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

30 patients who met the inclusion and exclusion criteria.

Group Type ACTIVE_COMPARATOR

Akamprosat or Naltrekson or combined medical treatment (Akamprosat and Naltrekson)

Intervention Type DRUG

Medicines prescribed by a doctor for the treatment of Alcohol Use Disorder (Akamprosat or Naltrekson or combined medical treatment (Akamprosat and Naltrekson))

Mobile game group

30 patients who met the inclusion and exclusion criteria.

Group Type EXPERIMENTAL

Mobile game app

Intervention Type OTHER

The mobile game designed to modify attentional bias toward alcohol-related cues was developed by integrating game elements into a modified version of the dot-probe task. This gamified intervention was installed on the smartphones of participants assigned to the experimental group, and each participant was provided with a unique username and password for access. Participants were instructed to engage with the mobile game every other day over one month.

Akamprosat or Naltrekson or combined medical treatment (Akamprosat and Naltrekson)

Intervention Type DRUG

Medicines prescribed by a doctor for the treatment of Alcohol Use Disorder (Akamprosat or Naltrekson or combined medical treatment (Akamprosat and Naltrekson))

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobile game app

The mobile game designed to modify attentional bias toward alcohol-related cues was developed by integrating game elements into a modified version of the dot-probe task. This gamified intervention was installed on the smartphones of participants assigned to the experimental group, and each participant was provided with a unique username and password for access. Participants were instructed to engage with the mobile game every other day over one month.

Intervention Type OTHER

Akamprosat or Naltrekson or combined medical treatment (Akamprosat and Naltrekson)

Medicines prescribed by a doctor for the treatment of Alcohol Use Disorder (Akamprosat or Naltrekson or combined medical treatment (Akamprosat and Naltrekson))

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being over the age of 18
* Ability to speak and understand Turkish
* Literacy (reading and writing)
* Ability to use a smartphone
* Having received a formal diagnosis of Alcohol Use Disorder (AUD)
* Receiving outpatient treatment and follow-up care for AUD
* Scoring 8 or higher on the Alcohol Use Disorders Identification Test (AUDIT)

Exclusion Criteria

* Currently experiencing an active psychotic episode
* Currently in a manic or hypomanic episode
* Having a neurodevelopmental or neurocognitive disorder
* Exhibiting symptoms of delirium
* Being under the influence of alcohol or other substances to a degree that negatively affects cognitive functioning
* Having participated as a qualitative data contributor in the initial phase of the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TC Erciyes University

OTHER

Sponsor Role collaborator

University of Yalova

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zehra Su Topbaş

research assistant

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Erenköy Ruh Ve Sinir Hastaliklari Eğitim Ve Araştirma Hastanesi

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Kvamme TL, Pedersen MU, Overgaard M, Thomsen KR, Voon V. Pilot study: Improving attention bias modification of alcohol cues through concealed gaze-contingent feedback in alcohol dependence. Addict Behav Rep. 2019 Nov 6;10:100231. doi: 10.1016/j.abrep.2019.100231. eCollection 2019 Dec.

Reference Type BACKGROUND
PMID: 31832536 (View on PubMed)

Heitmann J, van Hemel-Ruiter ME, Huisman M, Ostafin BD, Wiers RW, MacLeod C, DeFuentes-Merillas L, Fledderus M, Markus W, de Jong PJ. Effectiveness of attentional bias modification training as add-on to regular treatment in alcohol and cannabis use disorder: A multicenter randomized control trial. PLoS One. 2021 Jun 4;16(6):e0252494. doi: 10.1371/journal.pone.0252494. eCollection 2021.

Reference Type BACKGROUND
PMID: 34086751 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-KAEK/80

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PT150 Drug for Use in Alcohol Use Disorder
NCT06712602 RECRUITING PHASE1